Clearside Biomedical, Inc. (CLSD)
NASDAQ: CLSD · Real-Time Price · USD
0.8290
-0.0559 (-6.32%)
At close: Jul 14, 2025, 4:00 PM
0.8280
-0.0010 (-0.12%)
After-hours: Jul 14, 2025, 4:04 PM EDT
Clearside Biomedical Stock Forecast
Stock Price Forecast
The 4 analysts that cover Clearside Biomedical stock have a consensus rating of "Strong Buy" and an average price target of $4.75, which forecasts a 472.98% increase in the stock price over the next year. The lowest target is $3 and the highest is $6.
Price Target: $4.75 (+472.98%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 23, 2025.
Analyst Ratings
The average analyst rating for Clearside Biomedical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 2 | 2 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $5 | Strong Buy | Maintains | $6 → $5 | +503.14% | May 23, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $5 | Buy | Reiterates | $5 | +503.14% | May 16, 2025 |
| Needham | Needham | Strong Buy Maintains $4 → $3 | Strong Buy | Maintains | $4 → $3 | +261.88% | May 15, 2025 |
| Needham | Needham | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +382.51% | Apr 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +623.76% | Mar 31, 2025 |
Financial Forecast
Revenue This Year
4.05M
from 1.66M
Increased by 143.33%
Revenue Next Year
3.79M
from 4.05M
Decreased by -6.37%
EPS This Year
-0.42
from -0.47
EPS Next Year
-0.62
from -0.42
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.8M | 21.3M | 34.9M | ||
| Avg | 4.0M | 3.8M | 14.8M | ||
| Low | 2.3M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 549.9% | 426.2% | 821.8% | ||
| Avg | 143.3% | -6.4% | 290.9% | ||
| Low | 35.5% | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.19 | -0.21 | -0.24 | ||
| Avg | -0.42 | -0.62 | -0.51 | ||
| Low | -0.62 | -1.27 | -0.81 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.